20 top-selling drugs in the US

The IQVIA Institute for Human Data Science released a report detailing the 20 top-selling drugs in the U.S. by non-discounted spending. 

They are: 

1. Humira — $21.4 billion 
2. Eliquis — $9.9 billion 
3. Enbrel — $8.1 billion 
4. Stelara — $6.6 billion 
5. Keytruda — $6.5 billion
6. Trulicity — $6.5 billion 
7. Januvia — $6 billion 
8. Xarelto — $6 billion 
9. Biktarvy — $5.1 billion 
10. Remicade — $4.7 billion 
11. Opdivo — $4.4 billion 
12. Rituxan — $4.3 billion 
13. Lantus Solostar — $4.3 billion 
14. Symbicort — $3.9 billion 
15. Jardiance — $3.9 billion 
16. Genvoya — $3.8 billion 
17. Tecfidera — $3.8 billion 
18. Vyvanse — $3.7 billion 
19. Victoza 3-pak — $3.6 billion 
20. Ibrance — $3.6 billion 

Find the full report here.